We should stop burning pharma trials’ lab notes, with Ruxandra Teslo

We should stop burning pharma trials’ lab notes, with Ruxandra Teslo

Patrick McKenzie (patio11) is joined by Ruxandra Teslo to discuss why drug development keeps getting more expensive despite revolutionary new treatment modalities from GLP-1 agonists to gene therapies. They discuss Eroom’s Law (Moore’s Law in reverse) and Ruxandra's Common Technical Document Project, which aims to build the "Stack Overflow of clinical development" by making regulatory submissions publicly accessible. This will fill a present hole in the education of researchers, lower barriers for small biotechs, and accelerate drug discovery.

Full transcript available here: https://www.complexsystemspodcast.com/ruxandra-teslo/


Sponsor: Framer
Building and maintaining marketing websites shouldn’t slow down your engineers. Framer gives design and marketing teams an all-in-one platform to ship landing pages, microsites, or full site redesigns instantly—without engineering bottlenecks. Get 30% off Framer Pro at framer.com/complexsystems.


Links:
Eroom's Law (original paper): https://www.nature.com/articles/nrd3681
Ruxandra’s writing: https://www.writingruxandrabio.com/
Ross Rheingans-Yoo on drug development: https://open.spotify.com/episode/4GiO0KYqxJNCIdltCyhN6m?si=2znQniZ3RXKuX8keNcwWtw
Ben Reinhardt on science and development: https://open.spotify.com/episode/0GHegWgLSubYxvATmbWhQu?si=pVCJVITYTqaq65BiST2d0Q


Timestamps:
(00:00) Intro
(00:56) Challenges in biopharma productivity
(03:12) Understanding clinical development
(04:59) The role of basic science in drug development
(07:39) Clinical development process explained
(09:25) Issues in clinical trials and development
(19:33) The role of information in clinical trials
(20:30) Sponsor: Framer
(21:42) The role of information in clinical trials (continued)
(32:55) Proposed solutions for clinical development
(40:31) Consultant opinions and regulatory documents
(41:28) Streamlining the regulatory process
(43:06) Understanding FDA interactions
(45:35) Building a public library of regulatory documents
(48:18) Encouraging novel approaches in biotech
(50:06) Addressing risk aversion in the industry
(51:52) Analyzing FDA consistency and reviewer heterogeneity
(01:02:15) The importance of courage in professional growth
(01:06:39) Supporting young professionals and catalyzing change
(01:16:14) Wrap

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(104)

Everyone wants to be your wallet

Everyone wants to be your wallet

Patrick McKenzie (patio11) reads his Bits About Money essay on the business of wallets, with new commentary, prompted by paying his barber $100 over Venmo and wondering why PayPal so badly wants to be...

3 Sep 33min

How AI detection actually works, with Pangram’s Max Spero

How AI detection actually works, with Pangram’s Max Spero

Patrick McKenzie (patio11) is joined by Max Spero, co-founder and CEO of Pangram Labs, which builds models that identify AI-generated text and images. Max goes under the hood to explain how AI detecti...

27 Aug 1h 4min

Two banks can't agree on fourth-grade math | Alex Elliott

Two banks can't agree on fourth-grade math | Alex Elliott

Patrick McKenzie (@patio11) is joined by Alex Elliott (@alexpotato), who has spent his career in SRE and operations roles at financial firms ranging from ten-person fintechs to global investment banks...

20 Aug 1h 3min

LLMs and the economics of Evil, Inc., with Manish Goregaokar

LLMs and the economics of Evil, Inc., with Manish Goregaokar

Patrick McKenzie (patio11) is joined by Manish Goregaokar, a senior software engineer and member of the Rust security response team, to discuss what LLMs do to the cost side of running a sophisticated...

13 Aug 1h 2min

The economics of putting germicidal light in every room, with Misha Gurevich and Vivian Belenky of Aerolamp

The economics of putting germicidal light in every room, with Misha Gurevich and Vivian Belenky of Aerolamp

In this episode, Patrick McKenzie (patio11) is joined by Misha Gurevich, CEO of Aerolamp, and Vivian Belenky, its chief scientist and a researcher at Columbia, to discuss why UVC, a wavelength of ligh...

6 Aug 1h 16min

Cheap cognition, supercharged surveillance, and AI risks, with Garrison Lovely

Cheap cognition, supercharged surveillance, and AI risks, with Garrison Lovely

Patrick McKenzie (patio11) is joined by Garrison Lovely, journalist and author of Obsolete: The AI Industry's Trillion-Dollar Race to Replace Us and How to Stop It, to map the three-sided debate over ...

30 Jul 1h 20min

What you're actually getting paid in, with Leila Clark

What you're actually getting paid in, with Leila Clark

In this episode, Patrick McKenzie (patio11) is joined by Leila Clark, founder of Stardrift and formerly a software engineer at Jane Street, to discuss her essay "What Are You Getting Paid In?"  They c...

23 Jul 1h 4min

What LLMs can and can't do for writers, with Clara Collier of Asterisk Magazine

What LLMs can and can't do for writers, with Clara Collier of Asterisk Magazine

Patrick McKenzie is joined by returning guest Clara Collier, editor-in-chief of Asterisk Magazine, to discuss how working writers and reporters actually use LLMs. Patrick walks through the machinery b...

16 Jul 1h 35min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
lydartikler-fra-aftenposten
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
rss-skravla-gar
rss-pa-konto
pengepodden-2
finansredaksjonen
livet-pa-veien-med-jan-erik-larssen
rss-orjasater
utbytte
lederpodden
tid-er-penger-en-podcast-med-peter-warren
pengesnakk
morgenkaffen-med-finansavisen
stormkast-med-valebrokk-stordalen
rss-markedspuls-2
liberal-halvtime